Education
About Us
Working with TipRanks
Follow Us
Protagonist Therapeutics (PTGX)
NASDAQ:PTGX
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 46.02M | $ 434.43M | $ 60.00M | $ 26.58M | $ 27.36M |
| Gross Profit | $ 44.79M | $ 434.43M | $ 60.00M | $ 26.58M | $ 27.36M |
| Operating Income | $ -158.13M | $ 252.84M | $ -93.65M | $ -131.37M | $ -125.84M |
| EBITDA | $ -128.09M | $ 253.67M | $ -90.34M | $ -128.00M | $ -123.07M |
| Net Income | $ -130.15M | $ 275.19M | $ -78.95M | $ -127.39M | $ -125.55M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 567.36M | $ 418.91M | $ 341.62M | $ 237.35M | $ 326.90M |
| Total Assets | $ 669.89M | $ 744.73M | $ 357.95M | $ 247.93M | $ 347.69M |
| Total Debt | $ 10.32M | $ 10.87M | $ 1.14M | $ 3.66M | $ 5.86M |
| Net Debt | $ -118.07M | $ -86.38M | $ -185.59M | $ -122.09M | $ -117.81M |
| Total Liabilities | $ 55.19M | $ 69.43M | $ 21.27M | $ 32.32M | $ 47.67M |
| Stockholders' Equity | $ 614.71M | $ 675.29M | $ 336.68M | $ 215.61M | $ 300.02M |
| Cash Flow | |||||
| Free Cash Flow | $ 56.08M | $ 182.80M | $ -70.84M | $ -108.93M | $ -108.97M |
| Operating Cash Flow | $ 57.67M | $ 184.15M | $ -70.24M | $ -108.14M | $ -107.86M |
| Investing Cash Flow | $ -49.33M | $ -299.48M | $ -39.26M | $ 91.47M | $ -15.86M |
| Financing Cash Flow | $ 22.86M | $ 25.85M | $ 170.48M | $ 18.84M | $ 129.92M |